Package 43624-002-01

Brand: halaven

Generic: eribulin mesylate
NDC Package

Package Facts

Identity

Package NDC 43624-002-01
Digits Only 4362400201
Product NDC 43624-002
Product ID 43624-002_46b7876d-62f5-7a4f-e063-6394a90aa64a
Description

100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) / 3 mL in 1 TRAY

Marketing

Marketing Status
Marketed Since 2017-04-21
Brand halaven
Generic eribulin mesylate
Sample Package No

Linked Drug Pages (1)

Halaven ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "46b7876d-62f5-7a4f-e063-6394a90aa64a", "openfda": {"unii": ["AV9U0660CW"], "rxcui": ["1045456", "1045460"], "spl_set_id": ["8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6"], "manufacturer_name": ["BSP Pharmaceuticals SpA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01)  / 3 mL in 1 TRAY", "package_ndc": "43624-002-01", "marketing_start_date": "20170421"}], "brand_name": "Halaven", "product_id": "43624-002_46b7876d-62f5-7a4f-e063-6394a90aa64a", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "43624-002", "generic_name": "eribulin mesylate", "labeler_name": "BSP Pharmaceuticals SpA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Halaven", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "NDA201532", "marketing_category": "NDA", "marketing_start_date": "20170421", "listing_expiration_date": "20261231"}